دورية أكاديمية

CalScope: Monitoring Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence From Vaccination and Prior Infection in Adults and Children in California May 2021–July 2021.

التفاصيل البيبلوغرافية
العنوان: CalScope: Monitoring Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence From Vaccination and Prior Infection in Adults and Children in California May 2021–July 2021.
المؤلفون: Mehrotra, Megha L1 (AUTHOR) megha.mehrotra@cdph.ca.gov, Lim, Esther1 (AUTHOR), Lamba, Katherine1 (AUTHOR), Kamali, Amanda1 (AUTHOR), Lai, Kristina W1 (AUTHOR), Meza, Erika1 (AUTHOR), Szeto, Irvin2 (AUTHOR), Robinson, Peter3 (AUTHOR), Tsai, Cheng-ting3 (AUTHOR), Gebhart, David3 (AUTHOR), Fonseca, Noemi3 (AUTHOR), Martin, Andrew B2 (AUTHOR), Ley, Catherine2 (AUTHOR), Scherf, Steve4 (AUTHOR), Watt, James1 (AUTHOR), Seftel, David3 (AUTHOR), Parsonnet, Julie2 (AUTHOR), Jain, Seema1 (AUTHOR)
المصدر: Open Forum Infectious Diseases. Jul2022, Vol. 9 Issue 7, p1-10. 10p.
مصطلحات موضوعية: *SARS-CoV-2
مصطلحات جغرافية: CALIFORNIA
مستخلص: Background Understanding the distribution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies from vaccination and/or prior infection is critical to the public health response to the pandemic. CalScope is a population-based serosurvey in 7 counties in California. Methods We invited 200 000 randomly sampled households to enroll up to 1 adult and 1 child between April 20, 2021 and June 16, 2021. We tested all specimens for antibodies against SARS-CoV-2 nucleocapsid and spike proteins, and each participant completed an online survey. We classified participants into categories: seronegative, antibodies from infection only, antibodies from infection and vaccination, and antibodies from vaccination only. Results A total of 11 161 households enrolled (5.6%), with 7483 adults and 1375 children completing antibody testing. As of June 2021, 33% (95% confidence interval [CI], 28%–37%) of adults and 57% (95% CI, 48%–66%) of children were seronegative; 18% (95% CI, 14%–22%) of adults and 26% (95% CI, 19%–32%) of children had antibodies from infection alone; 9% (95% CI, 6%–11%) of adults and 5% (95% CI, 1%–8%) of children had antibodies from infection and vaccination; and 41% (95% CI, 37%–45%) of adults and 13% (95% CI, 7%–18%) of children had antibodies from vaccination alone. Conclusions As of June 2021, one third of adults and most children in California were seronegative. Serostatus varied regionally and by demographic group. [ABSTRACT FROM AUTHOR]
قاعدة البيانات: Academic Search Index
الوصف
تدمد:23288957
DOI:10.1093/ofid/ofac246